Julphar reports strong H1 2026 revenue of AED 573.7 million
Aug 14, 2026
Ras Al Khaimah [UAE], August 14: Gulf Pharmaceutical Industries PSC (Julphar) today announced its financial results for the six months ended 30 June 2026. The Company delivered continued revenue growth, improved margins and a significant increase in profitability from continuing operations, while maintaining a stable financing position following the successful deleveraging completed in 2025.
Read More...